Metis Global Partners LLC Has $4.88 Million Stock Position in Synopsys, Inc. $SNPS

Metis Global Partners LLC lifted its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS) by 15.5% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 9,894 shares of the semiconductor company’s stock after purchasing an additional 1,329 shares during the period. Metis Global Partners LLC’s holdings in Synopsys were worth $4,882,000 as of its most recent filing with the SEC.

Other institutional investors also recently modified their holdings of the company. Abich Financial Wealth Management LLC acquired a new position in Synopsys during the 3rd quarter worth about $115,000. Public Sector Pension Investment Board raised its position in shares of Synopsys by 32.7% during the third quarter. Public Sector Pension Investment Board now owns 19,494 shares of the semiconductor company’s stock worth $9,618,000 after acquiring an additional 4,807 shares during the last quarter. Atria Investments Inc raised its position in shares of Synopsys by 52.9% during the third quarter. Atria Investments Inc now owns 17,355 shares of the semiconductor company’s stock worth $8,563,000 after acquiring an additional 6,003 shares during the last quarter. Varma Mutual Pension Insurance Co boosted its holdings in Synopsys by 8.9% in the third quarter. Varma Mutual Pension Insurance Co now owns 30,565 shares of the semiconductor company’s stock valued at $15,080,000 after acquiring an additional 2,500 shares during the last quarter. Finally, Caisse Des Depots ET Consignations acquired a new stake in Synopsys during the 3rd quarter valued at approximately $904,000. Institutional investors own 85.47% of the company’s stock.

Insider Buying and Selling

In other Synopsys news, CFO Shelagh Glaser sold 3,657 shares of the company’s stock in a transaction on Friday, December 19th. The shares were sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the transaction, the chief financial officer owned 17,842 shares in the company, valued at approximately $8,221,058.34. This represents a 17.01% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Janet Lee sold 250 shares of the firm’s stock in a transaction on Monday, January 12th. The shares were sold at an average price of $530.00, for a total transaction of $132,500.00. Following the completion of the transaction, the insider directly owned 11,959 shares in the company, valued at $6,338,270. This trade represents a 2.05% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 4,157 shares of company stock worth $1,945,036 over the last ninety days. 0.62% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on SNPS. Bank of America upgraded shares of Synopsys from an “underperform” rating to a “neutral” rating and dropped their price target for the stock from $525.00 to $500.00 in a research report on Monday, December 8th. JPMorgan Chase & Co. boosted their target price on shares of Synopsys from $600.00 to $650.00 and gave the company an “overweight” rating in a report on Thursday, December 11th. Rosenblatt Securities raised shares of Synopsys from a “neutral” rating to a “buy” rating and cut their price target for the company from $605.00 to $560.00 in a research report on Tuesday, December 9th. Zacks Research upgraded Synopsys from a “strong sell” rating to a “hold” rating in a report on Monday, November 10th. Finally, Wall Street Zen raised Synopsys from a “sell” rating to a “hold” rating in a research note on Saturday, December 13th. Nine equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $553.57.

Synopsys Price Performance

Shares of NASDAQ SNPS opened at $437.09 on Friday. The firm has a market capitalization of $83.62 billion, a P/E ratio of 54.70, a P/E/G ratio of 3.53 and a beta of 1.12. The firm’s 50-day moving average price is $477.13 and its 200-day moving average price is $490.76. The company has a current ratio of 1.62, a quick ratio of 1.52 and a debt-to-equity ratio of 0.48. Synopsys, Inc. has a 1-year low of $365.74 and a 1-year high of $651.73.

Synopsys (NASDAQ:SNPS) last issued its earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 EPS for the quarter, beating the consensus estimate of $2.79 by $0.11. Synopsys had a return on equity of 7.89% and a net margin of 18.89%.The company had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.25 billion. During the same period last year, the business posted $3.40 EPS. The firm’s revenue for the quarter was up 37.8% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. Equities research analysts anticipate that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.

Synopsys Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.